Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine for Chronic Post-operative Pain in Emergency Abdominal Surgery
NCT07869173Phase 3Not yet recruiting
- Sponsor
- CHU de Nantes
- Start
- Jan 2027
- Primary completion
- Jul 2029
- Countries
- 1
01
Overview
A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine in chronic postsurgical pain (CPSP), sponsored by CHU de Nantes. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
chronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT07869173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07869173.